CEL-SCI Corp (CVM)
1.74
+0.11
(+6.75%)
USD |
NYAM |
May 06, 16:00
1.74
0.00 (0.00%)
After-Hours: 19:20
CEL-SCI Cash from Financing (Quarterly): 4.048M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.048M |
| September 30, 2023 | 4.066M |
| June 30, 2023 | 0.9516M |
| March 31, 2023 | -0.3884M |
| December 31, 2022 | 0.0654M |
| September 30, 2022 | -0.4717M |
| June 30, 2022 | -0.3486M |
| March 31, 2022 | 0.4384M |
| December 31, 2021 | -0.2565M |
| September 30, 2021 | 0.3149M |
| June 30, 2021 | 36.73M |
| March 31, 2021 | 4.152M |
| December 31, 2020 | 13.33M |
| September 30, 2020 | 0.0829M |
| June 30, 2020 | 10.31M |
| March 31, 2020 | 9.492M |
| December 31, 2019 | 5.15M |
| September 30, 2019 | 2.895M |
| June 30, 2019 | 8.673M |
| March 31, 2019 | 2.621M |
| December 31, 2018 | 0.6019M |
| September 30, 2018 | 12.26M |
| June 30, 2018 | 2.064M |
| March 31, 2018 | 4.674M |
| December 31, 2017 | 2.387M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.585M |
| June 30, 2017 | 2.828M |
| March 31, 2017 | 2.140M |
| December 31, 2016 | 3.708M |
| September 30, 2016 | 4.561M |
| June 30, 2016 | 4.598M |
| March 31, 2016 | 0.6015M |
| December 31, 2015 | 10.55M |
| September 30, 2015 | -0.1327M |
| June 30, 2015 | 14.87M |
| March 31, 2015 | -0.0021M |
| December 31, 2014 | 6.404M |
| September 30, 2014 | -0.002M |
| June 30, 2014 | 9.751M |
| March 31, 2014 | 2.413M |
| December 31, 2013 | 19.38M |
| September 30, 2013 | -0.021M |
| June 30, 2013 | -0.0017M |
| March 31, 2013 | -0.0017M |
| December 31, 2012 | 9.806M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 5.123M |
| March 31, 2012 | 5.051M |
| December 31, 2011 | 1.83M |
| September 30, 2011 | -1.366M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.4717M
Minimum
Sep 2022
36.73M
Maximum
Jun 2021
5.223M
Average
2.895M
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| Synlogic Inc | 19.58M |
| BioXcel Therapeutics Inc | 2.123M |
| IGM Biosciences Inc | 0.402M |
| Intelligent Bio Solutions Inc | 3.786M |
| Syra Health Corp | 5.019M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.888M |
| Cash from Investing (Quarterly) | -0.0649M |
| Free Cash Flow | -23.45M |
| Free Cash Flow Per Share (Quarterly) | -0.1022 |
| Free Cash Flow Yield | -29.47% |